NYSE:MED Medifast (MED) Stock Price, News & Analysis $18.51 -0.68 (-3.54%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$18.47▼$19.9550-Day Range$17.91▼$21.9652-Week Range$17.73▼$83.60Volume230,085 shsAverage Volume443,507 shsMarket Capitalization$202.44 millionP/E Ratio2.99Dividend YieldN/APrice Target$49.75 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Medifast alerts: Email Address Medifast MarketRank™ Stock AnalysisAnalyst RatingReduce1.50 Rating ScoreUpside/Downside168.8% Upside$49.75 Price TargetShort InterestHealthy20.45% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainability-4.00Upright™ Environmental ScoreNews Sentiment0.37Based on 3 Articles This WeekInsider TradingN/AProj. Earnings Growth-9.77%From $1.33 to $1.20 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.44 out of 5 starsConsumer Staples Sector62nd out of 136 stocksMiscellaneous Food Preparations & Kindred Products Industry2nd out of 5 stocks 2.8 Analyst's Opinion Consensus RatingMedifast has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageMedifast has only been the subject of 1 research reports in the past 90 days.Read more about Medifast's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted20.45% of the float of Medifast has been sold short.Short Interest Ratio / Days to CoverMedifast has a short interest ratio ("days to cover") of 4.2.Change versus previous monthShort interest in Medifast has recently decreased by 21.38%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldMedifast does not currently pay a dividend.Dividend GrowthMedifast does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Medifast is 106.45%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on EPS estimates, Medifast will have a dividend payout ratio of 550.00% in the coming year. This indicates that Medifast may not be able to sustain their current dividend.Read more about Medifast's dividend. Previous Next 2.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreMedifast has received a -1.18% net impact score from Upright. The largest negative impact of Medifast in category "GHG emissions" seems to be driven mostly by its "Meal replacement soups", "Meal replacement bars", "Meal replacement drinks", and "Protein bars" products. See details.Environmental SustainabilityThe Environmental Impact score for Medifast is -4.00. Previous Next 1.3 News and Social Media Coverage News SentimentMedifast has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Medifast this week, compared to 4 articles on an average week.Search InterestOnly 5 people have searched for MED on MarketBeat in the last 30 days. This is a decrease of -38% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Medifast to their MarketBeat watchlist in the last 30 days. This is a decrease of -57% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Medifast insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.50% of the stock of Medifast is held by insiders.Percentage Held by Institutions95.51% of the stock of Medifast is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Medifast's insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Medifast are expected to decrease by -9.77% in the coming year, from $1.33 to $1.20 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Medifast is 2.99, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 128.02.Price to Earnings Ratio vs. SectorThe P/E ratio of Medifast is 2.99, which means that it is trading at a less expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 22.25.Price to Book Value per Share RatioMedifast has a P/B Ratio of 0.99. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Medifast's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsWhat is Nvidia’s New $1 Trillion SuperProject?Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. About Medifast Stock (NYSE:MED)Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.Read More MED Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MED Stock News HeadlinesSeptember 4 at 10:40 AM | theglobeandmail.comSpotting Winners: Edgewell Personal Care (NYSE:EPC) And Personal Care Stocks In Q2September 4 at 5:39 AM | seekingalpha.comMedifast: Reorganization, GLP-1 Medication, And FCF Imply UndervaluationSeptember 7, 2024 | Sasco Gold LLC (Ad)Say Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late... August 30, 2024 | americanbankingnews.comZacks Research Analysts Boost Earnings Estimates for Medifast, Inc. (NYSE:MED)August 30, 2024 | americanbankingnews.comZacks Research Weighs in on Medifast, Inc.'s Q3 2024 Earnings (NYSE:MED)August 27, 2024 | seekingalpha.comMedifast Business Continues To Shrink, Stock Still RiskyAugust 25, 2024 | stockhouse.comThe Schall Law Firm Has Launched An Inquiry Into Medifast Inc And The Firm Is Seeking Investors To ParticipateAugust 24, 2024 | stockhouse.comA Securities Fraud Investigation Of Medifast Inc Has Been Opened By The Schall Law Firm And Stockholders Are Urged To Reach OutSeptember 7, 2024 | Sasco Gold LLC (Ad)Say Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late... August 17, 2024 | uk.finance.yahoo.comMedifast Inc (MDF.MU)August 12, 2024 | finance.yahoo.comMedifast's (NYSE:MED) Soft Earnings Don't Show The Whole PictureAugust 9, 2024 | bizjournals.comMedifast pivots again as revenue falls by 43%August 7, 2024 | finance.yahoo.comMedifast Second Quarter 2024 Earnings: Misses ExpectationsAugust 6, 2024 | seekingalpha.comMedifast, Inc. (MED) Q2 2024 Earnings Call TranscriptAugust 6, 2024 | theglobeandmail.comMedifast (NYSE:MED) Reports Sales Below Analyst Estimates In Q2 Earnings, Stock DropsAugust 6, 2024 | msn.comMedifast, Inc. (NYSE:MED) Q2 2024 Earnings Call TranscriptAugust 6, 2024 | finanznachrichten.deMedifast Announces Second Quarter 2024 Financial ResultsAugust 6, 2024 | markets.businessinsider.comAnalysts Offer Insights on Consumer Cyclical Companies: Penn National Gaming (PENN), Lincoln Edu (LINC) and Medifast (MED)See More Headlines Receive MED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medifast and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/05/2024Today9/07/2024Next Earnings (Estimated)11/04/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorConsumer Staples Industry Miscellaneous food preparations & kindred products Sub-IndustryPersonal Products Current SymbolNYSE:MED CUSIP58470H10 CIK910329 Webwww.medifast1.com Phone(410) 581-8042Fax410-581-8070Employees870Year FoundedN/APrice Target and Rating Average Stock Price Target$49.75 High Stock Price Target$82.00 Low Stock Price Target$17.50 Potential Upside/Downside+168.8%Consensus RatingReduce Rating Score (0-4)1.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$6.20 Trailing P/E Ratio2.99 Forward P/E Ratio13.92 P/E GrowthN/ANet Income$99.42 million Net Margins3.81% Pretax Margin4.84% Return on Equity25.77% Return on Assets17.04% Debt Debt-to-Equity RatioN/A Current Ratio2.98 Quick Ratio2.46 Sales & Book Value Annual Sales$770.18 million Price / Sales0.26 Cash Flow$10.58 per share Price / Cash Flow1.75 Book Value$18.77 per share Price / Book0.99Miscellaneous Outstanding Shares10,937,000Free Float10,664,000Market Cap$202.44 million OptionableOptionable Beta1.13 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Daniel R. Chard (Age 59)Executive Chairman & CEO Comp: $1.94MMr. James P. Maloney CPA (Age 56)Chief Financial Officer Comp: $823.91kMr. Anthony E. Tyree (Age 59)Chief Business Operations Officer Comp: $655.86kMr. Jason L. Groves Esq. (Age 53)Executive VP, General Counsel & Corporate Secretary Comp: $669.51kMr. Nicholas M. Johnson (Age 44)Chief Field Operations Officer Comp: $696.4kMr. Jonathan Barrett MacKenzie (Age 52)VP of Finance & Chief Accounting Officer Mr. Steven ZenkerVice President of Investor RelationsMs. Claudia C. Greninger (Age 51)Chief Human Resources Officer More ExecutivesKey CompetitorsHerbalifeNYSE:HLFUSANA Health SciencesNYSE:USNANu Skin EnterprisesNYSE:NUSNature's Sunshine ProductsNASDAQ:NATRVeruNASDAQ:VERUView All CompetitorsInsiders & InstitutionsSusquehanna International Group LLPBought 800 shares on 8/16/2024Ownership: 0.000%Quarry LPBought 2,282 shares on 8/16/2024Ownership: 0.024%Millennium Management LLCBought 128,719 shares on 8/15/2024Ownership: 4.290%AQR Capital Management LLCBought 210,669 shares on 8/15/2024Ownership: 3.565%Cubist Systematic Strategies LLCSold 5,200 shares on 8/14/2024Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions MED Stock Analysis - Frequently Asked Questions How have MED shares performed this year? Medifast's stock was trading at $67.22 on January 1st, 2024. Since then, MED shares have decreased by 72.5% and is now trading at $18.51. View the best growth stocks for 2024 here. How were Medifast's earnings last quarter? Medifast, Inc. (NYSE:MED) posted its quarterly earnings data on Monday, August, 5th. The specialty retailer reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.56. The specialty retailer earned $168.56 million during the quarter, compared to the consensus estimate of $160.44 million. Medifast had a trailing twelve-month return on equity of 25.77% and a net margin of 3.81%. What is Daniel Chard's approval rating as Medifast's CEO? 44 employees have rated Medifast Chief Executive Officer Daniel Chard on Glassdoor.com. Daniel Chard has an approval rating of 93% among the company's employees. This puts Daniel Chard in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. Who are Medifast's major shareholders? Top institutional shareholders of Medifast include Renaissance Technologies LLC (8.76%), Millennium Management LLC (4.29%), AQR Capital Management LLC (3.57%) and Acadian Asset Management LLC (3.09%). Insiders that own company stock include Daniel R Chard, Scott Schlackman, Andrea B Thomas, Jeffrey J Brown and Constance J Hallquist. View institutional ownership trends. How do I buy shares of Medifast? Shares of MED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Medifast own? Based on aggregate information from My MarketBeat watchlists, some other companies that Medifast investors own include NVIDIA (NVDA), Alibaba Group (BABA), AbbVie (ABBV), Home Depot (HD), Boeing (BA), Johnson & Johnson (JNJ) and Intel (INTC). This page (NYSE:MED) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medifast, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medifast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
